drugset / Trial / NCT02619513

Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks

NCT02619513 ↗

Phase 4 Completed 60 enrolled Weifeng Tu
RandomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to explore the effectiveness of dexmedetomidine as an adjunctive analgesic, used in ultrasound-guided continuous thoracic paravertebral blocks for Post-thoracotomy Pain Syndrome(PTPS).

Timeline

Start
2014-12
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 100 ug Other
Background Ropivacaine Other / unclassified — Other

Indications

No indication recorded.